Profile
| Metric | Value |
|---|---|
| Full Name | Acurx Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ACXP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | acurxpharma.com |
| Employees | 4 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $2.68 | |
| Price, 1D Change | -2.19% | |
| $4M | ||
| - | ||
| - | ||
| 0.71 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$17.45 | ||
| EPS, 1Y Change | -1,416.93% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$17.45 | ||
| EPS Estimate | -$5.71 | |
| EPS Est. Change | +67.28% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $2.68 | |
| Price Target | - | $30.50 |
| Price Tgt. Change | - | +1,038.06% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.03 | -$1.15 | -11.69% | |
| -$0.89 | -$17.45 | -1,860.76% | |
| -$5.71 | N/A | +67.28% | |
| -$3.71 | N/A | +78.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $2.68 | |
| $6.10 | ||
| SMA 200 vs Price | +127.69% | |
| $3.74 | ||
| SMA 50 vs Price | +39.37% | |
| 0.71 | ||
| $0.26 | ||
| 34.82 | ||
| 67.58% | ||
| 215.63% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$17.45 | ||
| $0.00 | ||
| - | ||
| -$14.10M | ||
| - | ||
| -$14.10M | ||
| - | ||
| -$14.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 1.19 | ||
| 1.19 | ||
| - | ||
| - | ||
| -35.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.13 | ||
| 0.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $615.10K | ||
| $3.71M | ||
| $3.86M | ||
| $3.86M | ||
| $3.24M | ||
| $3.24M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $14.10M | ||
| $14.10M | ||
| $0.00 | ||
| $8.70M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$10.38M | ||
| $0.00 | ||
| $6.62M | ||
| $0.00 | ||
| -$10.38M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ACXP
Data Sources & References
- ACXP Official Website www.acurxpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1736243/000110465925109698/0001104659-25-109698-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1736243/000155837025003117/0001558370-25-003117-index.htm
- ACXP Profile on Yahoo Finance finance.yahoo.com/quote/ACXP
- ACXP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acxp
FAQ
What is the ticker symbol for Acurx Pharmaceuticals, Inc.?
The ticker symbol for Acurx Pharmaceuticals, Inc. is NASDAQ:ACXP
Does Acurx Pharmaceuticals, Inc. pay dividends?
No, Acurx Pharmaceuticals, Inc. does not pay dividends
What sector is Acurx Pharmaceuticals, Inc. in?
Acurx Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Acurx Pharmaceuticals, Inc. in?
Acurx Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Acurx Pharmaceuticals, Inc. based in?
Acurx Pharmaceuticals, Inc. is headquartered in United States
When did Acurx Pharmaceuticals, Inc. go public?
Acurx Pharmaceuticals, Inc. initial public offering (IPO) was on June 25, 2021
Is Acurx Pharmaceuticals, Inc. in the S&P 500?
No, Acurx Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Acurx Pharmaceuticals, Inc. in the NASDAQ 100?
No, Acurx Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Acurx Pharmaceuticals, Inc. in the Dow Jones?
No, Acurx Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Acurx Pharmaceuticals, Inc. last earnings report?
Acurx Pharmaceuticals, Inc.'s most recent earnings report was on November 12, 2025
When does Acurx Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Acurx Pharmaceuticals, Inc. is March 17, 2026